AllianceBernstein (AB)
(Delayed Data from NYSE)
$33.21 USD
-0.18 (-0.54%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $33.18 -0.03 (-0.09%) 5:08 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AB 33.21 -0.18(-0.54%)
Will AB be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AB
AllianceBernstein's (AB) April AUM Falls on Market Depreciation
AB vs. SEIC: Which Stock Is the Better Value Option?
AB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Finance Stocks Lagging Bain Capital Specialty Finance (BCSF) This Year?
Are Investors Undervaluing AllianceBernstein (AB) Right Now?
Why AllianceBernstein (AB) Might Surprise This Earnings Season
Other News for AB
AllianceBernstein launches two short-duration bond ETFs
AllianceBernstein Finalizes Two New ETF Conversions
AllianceBernstein: Office Space: Looking Past the Doom and Gloom
Analysts Offer Insights on Financial Companies: AllianceBernstein (AB) and Enova International (ENVA)
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS